Czech President Signs Law Limiting Medicine Re-Exports – But Will It Work?
An amendment to the Medicines Act designed to limit distributors’ ability to parallel export medicines to higher priced EU markets has been signed, but some lawyers argue it might not be fit for purpose.
You may also be interested in...
The EU Heads of Medicines Agencies has outlined some of the recent initiatives taken by the member states to deal with medicines shortages, including a new Dutch center and a member state coordinating initiative by the Irish regulator.
European parallel traders are unhappy with a Czech government proposal to draw up a list of “irreplaceable” medicines that are subject to restrictions on re-exportation.
Europe’s Innovative Medicines Initiative is to get €90m in funding for programs targeting the coronavirus outbreak.